year 24, Issue 95 (10-2025)
J. Med. Plants 2025, 24(95): 35-44 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hamoonnavard S, Rezvan H, Behdarvand F, Bazargani-Gilani B, Mousavi M. In vitro anti-leishmanial activity of Boswellia sacra gum resin extract on Leishmania major promastigotes. J. Med. Plants 2025; 24 (95) :35-44
URL: http://jmp.ir/article-1-3695-en.html
URL: http://jmp.ir/article-1-3695-en.html
Sahar Hamoonnavard *1 
, Hossein Rezvan2 , Fatemeh Behdarvand2 , Behnaz Bazargani-Gilani3 , Mahshid Mousavi2
, Hossein Rezvan2 , Fatemeh Behdarvand2 , Behnaz Bazargani-Gilani3 , Mahshid Mousavi2
1- Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran , s.hamoonnavard@basu.ac.ir
2- Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran
3- Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran
2- Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran
3- Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran
Abstract: (205 Views)
Background: The adverse effects of traditional chemical treatments have driven interest in herbal compounds for leishmaniasis therapy. Objective: This study aimed to investigate the anti-leishmanial effect of Boswellia sacra gum resin extract on the survival of Leishmania major promastigotes. Methods: Leishmania major strain (MHOM/IR/75/ER) was adjusted to 2 × 105 parasites per well. Promastigotes were exposed to a range of B. sacra gum resin extract concentrations (15, 25, 50, 70, 100, 200, 400, 800, 1600, and 3200 µg/ml) for 24 hours. Viability and cytotoxic effects were assessed using the MTT assay (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) with absorbance measured at 450 nm. Result: The B. sacra gum resin extract reduced promastigotes viability at various concentrations, with statistically significant effects observed at 800, 1600, and 3200 µg/mL (P ≤ 0.05). Cytotoxic effects at 1600 and 3200 µg/mL were significantly greater than those at 15, 25, and 50 µg/mL (P ≤ 0.01). Conclusion: Based on the in vitro anti-leishmanial activity observed, Boswellia sacra resin extract warrants further investigation as a potential agent against cutaneous leishmaniasis. Future in vivo studies are recommended to evaluate efficacy and safety.
Type of Study: Research |
Subject:
Medicinal Plants
Received: 2024/07/6 | Accepted: 2025/08/9 | Published: 2025/10/2
Received: 2024/07/6 | Accepted: 2025/08/9 | Published: 2025/10/2
References
1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer Md, WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global estimates of its incidence. PloS one 2012; 7(5): e35671. [DOI:10.1371/journal.pone.0035671]
2. Salgado VR, Queiroz ATd, Sanabani SS, Oliveira CId, Carvalho EM, Costa JM, Barral-Netto M and Barral A. The microbiological signature of human cutaneous leishmaniasis lesions exhibits restricted bacterial diversity compared to healthy skin. Mem. Inst. Oswaldo Cruz. 2016, 111(4): 241-251. [DOI:10.1590/0074-02760150436]
3. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A and Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006; 3(5): e162. [DOI:10.1371/journal.pmed.0030162]
4. Gharirvand Eskandari E, Setorki M, Doudi M: Medicinal plants with antileishmanial properties: A review study. Pharm. Biomed. Res. 2020; 6(1): 1-16. [DOI:10.18502/pbr.v6i1.3422]
5. Moghaddas E, Khamesipour A, Mohebali M and Abdolmajid F: Iranian native plants on treatment of cutaneous leishmaniosis: A narrative review. Iran. J. Parasitol. 2017; 12(3): 312.
6. Ammon HPT. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien. Med. Wochenschr. 2002; 152(15-16): 373-378. [DOI:10.1046/j.1563-258X.2002.02056.x]
7. Al-Saidi S, Rameshkumar K, Hisham A, Sivakumar N and Al-Kindy S. Composition and antibacterial activity of the essential oils of Four commercial grades of Omani Luban, the Oleo-Gum Resin of Boswellia sacra Flueck. Chem. Biodivers. 2012; 9(3): 615-624. [DOI:10.1002/cbdv.201100189]
8. Başer KHC, Demirci B, Dekebo A and Dagne E. Essential oils of some Boswellia spp., myrrh and opopanax. Flavour Frag. J. 2003; 18(2): 153-156. [DOI:10.1002/ffj.1166]
9. Al-Harrasi A and Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban). Molecules. 2008; 13(9): 2181-2189. [DOI:10.3390/molecules13092181]
10. Iram F, Khan SA and Husain A. Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review. Asian Pacific J. Tropical. Biomed. 2017; 7(6): 513-523. [DOI:10.1016/j.apjtb.2017.05.001]
11. Almutairi MBF, Alrouji M, Almuhanna Y, Asad M and Joseph B. In-vitro and In-vivo antibacterial effects of Frankincense oil and its interaction with some antibiotics against multidrug-resistant pathogens. Antibiotics 2022; 11(11): 1591. [DOI:10.3390/antibiotics11111591]
12. Di Stefano V, Schillaci D, Cusimano MG, Rishan M and Rashan L. In vitro antimicrobial activity of frankincense oils from Boswellia sacra grown in different locations of the Dhofar region (Oman). Antibiotics. 2020; 9(4): 195. [DOI:10.3390/antibiotics9040195]
13. Ismail SM, Aluru S, Sambasivarao K and Matcha B. Antimicrobial activity of frankincense of Boswellia serrata. Int. J. Curr. Microbiol. App. Sci. 2014; 3(19): 1095-1101.
14. Karlina MV, Pozharitskaya ON, Kosman VM and Ivanova S. Bioavailability of boswellic acids: in vitro/in vivo correlation. Pharm Chem J. 2007; 41(11): 569-572. [DOI:10.1007/s11094-008-0017-x]
15. Miran M, Amirshahrokhi K, Ajanii Y, Zadali R, Rutter MW, Enayati A and Movahedzadeh F. Taxonomical investigation, chemical composition, traditional use in medicine, and pharmacological activities of Boswellia sacra flueck. Evid. Based Complement. Alternat. Med. 2022; 2022; 8779676. [DOI:10.1155/2022/8779676]
16. Pandey RS, Singh BK and Tripathi YB. Extract of gum resins of Boswellia serrata L. inhibits lipopolysaccharide induced nitric oxide production in rat macrophages along with hypolipidernic property. Indian J. Exp. Biol. 2005; 43(6): 509-16.
17. Knaus U and Wagner H. Effects of boswellic acid of Boswellia serrata and other triterpenic acids on the complement system. Phytomedicine. 1996; 3(1): 77-80. [DOI:10.1016/S0944-7113(96)80016-X]
18. Sadeghi F, Khalaj-Kondori M, Feizi H and Shaikhzadeh Hesari F. The effect of aqueous extract of Boswellia on learning and spatial memory in adult male rats. J. Adv. Med. Biomed. Res. 2014; 22(95): 122-131.
19. Zahiri M, Mohebali M, Khanavi M, Sahebgharani M, Saghafipour A, Esmaeili J, Hajjaran H, Akhavan AA and Rezayat SM. Therapeutic effect of Scrophularia striata ethanolic extract against localized cutaneous leishmaniasis caused by Leishmania major (MRHO/IR/75/ER). Iran. J. Public Health 2016; 45(10): 1340-1347.
20. Farahani MK, Bitaraf FS, Atashi A and Jabbarpour Z. Evaluation of anticancer effects of frankincense on breast cancer stem-like cells. Cancer Rep. 2023; 6(2): e1693. [DOI:10.1002/cnr2.1693]
21. Hartmann RM, Morgan Martins MI, Tieppo J, Fillmann HS and Marroni NP. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid. Dig. Dis. Sci. 2012; 57(8): 2038-2044. [DOI:10.1007/s10620-012-2134-3]
22. Rashan L, White A, Haulet M, Favelin N, Das P and Cock IE. Chemical composition, antibacterial activity, and antibiotic potentiation of Boswellia sacra Flueck. oleoresin extracts from the Dhofar region of Oman. Evid-Based Complement. Alternat. Med. 2021; 9918935. [DOI:10.1155/2021/9918935]
23. Sharma ML, Kaul A, Khajuria A, Singh S and Singh GB. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother Res. 1996; 10(2): 107-112. https://doi.org/10.1002/(SICI)1099-1573(199603)10:2<107::AID-PTR780>3.0.CO;2-3 [DOI:10.1002/(SICI)1099-1573(199603)10:23.0.CO;2-3]
24. Schmidt TJ, Kaiser M and Brun R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activity. Planta Medica 2011; 77(8): 849-850. [DOI:10.1055/s-0030-1250612]
25. Mukherjee PK, Nema NK, Bhadra S, Mukherjee D, Braga FC and Matsabisa MG. Immunomodulatory leads from medicinal plants. Indian J. Tradit. Know. 2014; 13(2): 235-6. [DOI:10.1016/B978-0-12-397153-1.00022-6]
26. Babaei M, Youssefi MR and Nasrabadi NT. In vitro evaluation of antileishmanial activity of Boswellia serrata essential oil nanoliposome. Vet. Med. Sci. 2024; 10(2): e1400. [DOI:10.1002/vms3.1400]
27. Greve HL, Kaiser M, Mäser P and Schmidt TJ. Boswellic acids show in vitro activity against Leishmania donovani. Molecules. 2021; 26(12): 3651. [DOI:10.3390/molecules26123651]
28. Sharifi-Rad J, Sureda A, Tenore GC, Daglia M, Sharifi-Rad M, Valussi M, Tundis R, Sharifi-Rad M, Loizzo MR, Ademiluyi AO, Sharifi-Rad R, Ayatollahi SA and Iriti M. Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules. 2017; 22(1): 70. [DOI:10.3390/molecules22010070]
29. Lee H-Y, Yun M-Y and Kang S-M Anti-inflammatory effect of Boswellia sacra (Franckincense) essential oil in a mouse model of allergic asthma. Microbiol. Biotechnol. Letters 2008; 36(4): 343-352.
30. Solanki N, Gupta G, Chellappan DK, Singh SK, Gulati M, Paudel KR, Hansbro PM, Dua K, Bhan S, Saini M and Dureja H. Boswellic acids: A critical appraisal of their therapeutic and nutritional benefits in chronic inflammatory diseases. Endocr. Metab. Immune Disord. Drug Targets. 2024; 24(1): 116-129. [DOI:10.2174/1871530323666230512154634]
31. Ammon HPT. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006; 72(12): 1100-1116. [DOI:10.1055/s-2006-947227]
32. Almjalawi BSA, Alhamed TA and Alhesnawi ASM. Antibacterial activity of Boswellia carterii aqueous extract and its effect on phagocytosis in vitro. Arch. Razi. Inst. 2022; 77(2): 545-552.
33. Soltani M, Etminan A, Rahmati A, Behjati Moghadam M, Ghaderi Segonbad G and Homayouni Tabrizi M. Incorporation of Boswellia sacra essential oil into chitosan/TPP nanoparticles towards improved therapeutic efficiency. Mater Technol. 2022; 37(1): 1-13. [DOI:10.1080/10667857.2021.1976364]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
